Verified earnings results
Compass Therapeutics Q2 2026 Earnings Results
Compass Therapeutics Q2 2026 reported revenue, operating income and net income.
Direct answer
Compass Therapeutics reported Q2 2026 results on August 6, 2026.
Revenue was 0. EPS missed the estimate by 17.65%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 6, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.1105
- Reported EPS
- -0.13
- Revenue
- 0
- EPS surprise
- EPS missed the estimate by 17.65%.
Explore related company data
Read the frequently asked questions.
When did Compass Therapeutics report Q2 2026 earnings?
Compass Therapeutics reported on August 6, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Compass Therapeutics?
The verified record provides an EPS estimate of -0.1105.
Has Compass Therapeutics reported the Q2 2026 result?
Revenue was 0. EPS missed the estimate by 17.65%.
Which source supports this Compass Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.